Akyla AKYLA
Equity Research Advanced Materials / Metal-Matrix Composites Initiation of Coverage — LONG Last Updated: June 28, 2026

CPS Technologies Corp. (CPSH)

Capacity-led turnaround into defense/EV/semiconductor demand for AlSiC metal-matrix composites; FY2025 swing to GAAP profit is the inflection. Initiating LONG with a ~2x bridge.

Thesis

  1. The inflection already happened in the income statement. CPS swung from a -$3.14M GAAP net loss in FY2024 to +$0.42M net income in FY2025 on $32.6M revenue (+54% YoY), with gross profit going from -$0.12M to +$5.29M. The business crossed breakeven on volume — the operating model now has demonstrated leverage, not a hypothetical one.
  2. This is a capacity-constrained story, not a demand-constrained one. The May 2026 secondary (424B5, filed 2026-05-29) raises fresh equity explicitly to fund capacity expansion for AlSiC baseplates (power electronics for EV, rail, and defense) and HybridTech armor. Demand for metal-matrix composites in defense radar/avionics and EV/rail power modules is the secular pull; CPS's constraint has been throughput.
  3. PATH TO 2x: We bridge the ~$97M market cap to ~$190M (≈$10/sh) by mid-2028 via a tied-out chain — revenue scaling toward ~$50M on the new capacity, gross margin normalizing back toward the high-teens (FY2025 was 16.2%; FY2023-era peaks were higher), and a modest small-cap re-rating to ~3.8x P/S. The math is shown explicitly in the Valuation section. It requires execution, not heroics.
  4. The comp set frames the re-rating optionality. Materials/display peers KOPN and OLED trade at 30.5x and 7.3x TTM P/S respectively; CPSH trades at ~3.0x TTM revenue today. We do NOT underwrite peer multiples — we use a conservative ~3.8x end-state — but the gap shows how a profitable, growing MMC franchise could re-rate.
  5. Honest about the air-pocket: Q1 2026 (period ending 2026-03-28) was soft — revenue $7.03M with gross margin collapsing to 8.6% and a return to a -$0.29M net loss. We treat this as a lumpy, project-driven quarter rather than a trend reversal, but the thesis is explicitly contingent on margin re-normalizing as volume and mix recover on the expanded capacity.

Q1 FY27 Earnings Snapshot

Q1 2026 Revenue
Quarter ended 2026-03-28
Q1 2026 Gross Margin
8.6%
GP $0.61M / Rev $7.03M
FY2025 Net Income
Swing from -$3.14M in FY2024
FY2025 Revenue
+54% YoY vs $21.1M FY2024

The story has two clocks running at different speeds, and the gap between them is the opportunity. On the annual clock, FY2025 is unambiguously the inflection: revenue of $32.60M was up 54% from $21.12M in FY2024, gross profit swung from -$0.12M to +$5.29M (16.2% margin), operating income went from -$4.38M to +$0.44M, and net income crossed into the black at +$0.42M ($0.03 diluted EPS) from -$3.14M (-$0.22) the year prior. That is a genuine operating-leverage breakthrough — the same plant absorbing far more volume and converting it to profit. On the quarterly clock, however, Q1 2026 (ended 2026-03-28) was an air-pocket: revenue of $7.03M held up versus the $7.51M of Q1 2025, but gross margin compressed to 8.6% (from 16.4% in Q1 2025 and 17.1% in Q3 2025), pushing operating income to -$0.52M and net income to -$0.29M (-$0.02 EPS). The compression looks mix- and throughput-driven rather than structural: CPS's revenue is project-and-program lumpy, and COGS of $6.42M on flat-ish revenue indicates an unfavorable absorption/mix quarter, not pricing collapse. We read Q1 2026 as noise around an improving trend — but it is exactly the line item the bull case lives or dies on, so we track quarterly gross margin as the single most important tell. Notably, diluted share count stepped up to ~18.0M in Q1 2026 from ~14.5M a year earlier, reflecting equity issuance ahead of the May 2026 capacity raise — real dilution that the revenue ramp must outrun.

Continue reading

Read the full CPSH report

The full thesis — earnings detail, financial model, valuation and price target — is free. Enter your email to unlock the rest of the report.

Unlock the full report →

No account, no payment — just your email. For informational purposes only — not investment advice.

Disclaimer

This is not financial advice.

This report is for informational purposes only and is not investment advice.